Pliant Therapeutics, Inc. · NASDAQ:PLRX

Citadel Advisors LLC's stake in Pliant Therapeutics, Inc. fell to 4.90% (Schedule 13G)

Event Jan 14, 2026 · Filed Jan 22, 2026

Citadel Advisors LLC's stake in Pliant Therapeutics, Inc. fell to 4.90%, 2,991,915 shares, as a passive investor on Jan 14, 2026. Filed Jan 22, 2026 (Schedule 13G).

Stake
4.90%
Shares
2,991,915
Intent
Passive
What changed
Fell below 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC3.40%2,099,798
Citadel Advisors Holdings LP3.40%2,099,798
Citadel GP LLC3.40%2,099,798
Citadel Securities LLC1.40%863,391
Citadel Securities Group LP1.50%892,117
Citadel Securities GP LLC1.50%892,117
Kenneth Griffin4.90%2,991,915

Source

View original at SEC

Related